enGene Holdings Inc. Ratios

Ratios Oct2022 Oct2023 Oct2024 Oct2025
Profitability
EBT Margin 1,717.50%2,016.96%1,971.44%3,917.90%
EBIT Margin 1,365.21%526.15%2,226.48%4,113.73%
EBITDA Margin 1,637.03%2,017.30%1,956.36%3,900.17%
Operating Margin 1,365.21%526.15%2,226.48%4,113.73%
Net Margin 2,039.63%2,114.66%1,970.76%3,917.90%
FCF Margin 1,247.01%505.98%1,758.61%3,364.20%
Leverage & Solvency
Interest Coverage Ratio -13.65-5.26-22.26-41.14
Times Interest Earned -13.65-5.26-22.26-41.14
Valuation
Enterprise Value 160.50M503.28M391.31M371.97M
Market Capitalization 160.50M503.28M391.31M371.97M
Return Ratios
Return on Sales 17.19%20.17%19.71%39.18%